Medical Condition News

RSS

Dementia sufferers and caregivers unhappy with quality of care

Dementia patients and their families have been asked to assess the quality of care available to them. Their reports are far from satisfactory. Alzheimer's Australia says dementia patients and their carers are being let down right across the health system. The Federal Government has promised to use the report to help decide how to improve the system.

9 Apr 2012

Berries may reduce Parkinson’s disease risk in men: Study

A new study has found that men who regularly consume foods rich in flavonoids, such as berries, apples, certain vegetables, tea and red wine, may significantly reduce their risk for developing Parkinson's disease. The study was published in the journal Neurology this week. It added that there was no such effect among women.

9 Apr 2012

FDA approves scan to detect Alzheimer’s disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

9 Apr 2012

Stealth announces results from three Bendavia Phase I clinical trials for mitochondrial dysfunction

Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.

9 Apr 2012

USPTO issues Notice of Allowance for Sunshine Biopharma's anti-tumor compound patent application

Sunshine Biopharma Inc. is pleased to announce that it has recently received notification that the United States Patent and Trademark Office has issued a "Notice of Allowance" for the patent application covering its lead anti-tumor compound, Adva-27a. The allowed claims protect Adva-27a and extensively cover various formulations, derivatives and cancer applications.

9 Apr 2012

Med-Tek introduces proprietary Opioid Management Program

Med-Tek a developer of Healthcare Technology Networks ("HTN") designed to improve outcomes for patients, physicians, employers and their constituents today announces the launch of its proprietary Opioid Management Program (OMP).

9 Apr 2012

Study shows causal effect of obesity on medical care costs

Obesity now accounts for almost 21 percent of U.S. health care costs - more than twice the previous estimates, reports a new Cornell University study.

9 Apr 2012

Novel anti-leukemia compound with little toxicity successfully treats zebrafish

A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans - even those resistant to conventional therapies - according to results from a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

9 Apr 2012

Synapse Medical acquires another MicroThermX Microwave Ablation System

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has sold an additional MicroThermX Microwave Ablation System to Synapse Medical Ltd.

9 Apr 2012

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) are developing new methods to inject drugs and genetic payloads directly into cancer cells.

9 Apr 2012

New text messaging program to manage diabetes

D.C. Chartered Health Plan, Inc., the oldest Medicaid managed care organization in the District of Columbia, is launching a new text messaging program for 50 of its members to help them better manage diabetes, which requires regular care to avoid costly complications.

9 Apr 2012

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Bioness Inc. today announced the initiation of a study to evaluate the safety and effectiveness of the company's StimRouter Neuromodulation System for those suffering from chronic peripheral nerve pain. This prospective, multi-center, randomized, double-blinded, partial crossover study will enroll 126 patients at up to 10 study sites throughout the United States.

9 Apr 2012

Japanese MHLW approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Abbott today announced it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the next-generation XIENCE PRIME Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

9 Apr 2012

Five significant genetic associations for hypothyroidism found

Using its unique online research platform, 23andMe, a leading personal genetics company, has found five significant genetic associations for hypothyroidism in the largest known genome-wide association study of hypothyroidism conducted to date. The details of the study are now available online in the journal PLoS ONE.

9 Apr 2012

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

Winston Pharmaceuticals, Inc.,, announced that the National Institutes of Health has awarded Winston a grant under the Small Business Innovation Research program supporting the development of Civamide, a proprietary TRPV-1 receptor modulator, for the treatment of postherpetic neuralgia of the trigeminal nerve.

9 Apr 2012

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

Niacin, or vitamin B3, is the one approved drug that elevates "good" cholesterol (high density lipoprotein, HDL) while depressing "bad" cholesterol (low density lipoprotein , LDL), and has thereby attracted much attention from patients and physicians. Niacin keeps fat from breaking down, and so obstructs the availability of LDL building blocks.

9 Apr 2012

Heart cells starved of nutrients less likely to be damaged during ischemia, reperfusion

Heart cells starved of nutrients are less likely to be damaged during periods of decreased blood flow and sudden influxes of blood, known as ischemia and reperfusion, and are also less likely to get out of synch with their cellular neighbors, the damaging phenomenon called arrhythmia.

9 Apr 2012

Nuron Biotech licenses DNA amyloid beta 42 vaccine for AD

Nuron Biotech, Inc. today announced it has licensed from VITRUVIAN BioMedical, Inc. a gene-based (DNA) amyloid beta 42 (Aβ42) vaccine in preclinical development for Alzheimer's disease (AD).

9 Apr 2012

NINDS awards NeuroSigma Phase I grant to develop TFN-covered stents

NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms.

9 Apr 2012

Inflammasome involved in regulating Age-Related Macular Degeneration

Scientists at Trinity College Dublin have discovered that a part of the immune system called the inflammasome is involved in regulating the development of one of the most common forms of blindness, called Age-Related Macular Degeneration.

9 Apr 2012

Medical Condition News

Dementia sufferers and caregivers unhappy with quality of care

Berries may reduce Parkinson’s disease risk in men: Study

FDA approves scan to detect Alzheimer’s disease early

Stealth announces results from three Bendavia Phase I clinical trials for mitochondrial dysfunction

USPTO issues Notice of Allowance for Sunshine Biopharma's anti-tumor compound patent application

Med-Tek introduces proprietary Opioid Management Program

Study shows causal effect of obesity on medical care costs

Novel anti-leukemia compound with little toxicity successfully treats zebrafish

Synapse Medical acquires another MicroThermX Microwave Ablation System

Delivering chemotherapy drugs with nanobubbles more deadly to cancer cells

New text messaging program to manage diabetes

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Japanese MHLW approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System

Five significant genetic associations for hypothyroidism found

NIH awards Winston SBIR grant to develop Civamide for postherpetic neuralgia of TN

Researchers question wisdom of blocking DP1 in patients prone to cardiovascular disease

Heart cells starved of nutrients less likely to be damaged during ischemia, reperfusion

Nuron Biotech licenses DNA amyloid beta 42 vaccine for AD

NINDS awards NeuroSigma Phase I grant to develop TFN-covered stents

Inflammasome involved in regulating Age-Related Macular Degeneration

In the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic Immunotherapy

Making Complex Cell Culture Easy and Efficient with AI

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Latest News